Cardiology
Conference Coverage
Cardiac rehab also slashes stroke risk
ROME – Participation in contemporary cardiac rehabilitation programs reduces the risk of a cerebrovascular event by 60%, compared with usual post-...
Conference Coverage
Interatrial shunt benefits sustained for 1 year in HFpEF patients
NEW ORLEANS – An interatrial septal shunt device continued to provide “sustained and meaningful clinical benefit” at 1-year follow-up in patients...
Conference Coverage
VIDEO: Bariatric surgery may protect against heart failure
NEW ORLEANS – Bariatric surgery appears to reduce substantially the risk of heart failure.
From the Journals
CSL112 enhances cholesterol efflux capacity after acute MI
CSL112, a plasma-derived apolipoprotein A-1 (apoA-1) that enhances cholesterol efflux capacity, was found safe for use after acute MI in a...
Conference Coverage
Heart failure readmission metric not linked to care quality
A new analysis suggests that metrics used by CMS to determine penalties for heart failure hospital readmissions are not associated with quality of...
Conference Coverage
VIDEO: Celecoxib just as safe as naproxen or ibuprofen in OA and RA
WASHINGTON - Celecoxib conferred a 53% decreased risk of overall mortality upon patients with rheumatoid arthritis when compared with naproxen - a...
Conference Coverage
No primary prevention gains from low-dose aspirin in diabetes
A daily regimen of low-dose aspirin does not appear to reduce the risk of cardiovascular events in individuals with type 2 diabetes in the absence...
Feature
USPSTF: Expand statin use beyond lipids to CVD risk
USPSTF now recommends low- to moderate-dose statins for primary prevention in adults 40-75 years old who have at least one CVD risk factor and a...
Conference Coverage
VIDEO: Blood pressure and LDL lowering in elderly do not slow cognitive decline
NEW ORLEANS – Patients in their 70s and early 80s get the cardiovascular benefits of statin therapy without increased risk of cognitive decline....
Conference Coverage
VIDEO: PRECISION exonerates celecoxib: cardiovascular risk is no worse than that of nonselective NSAIDs
NEW ORLEANS – The cardiovascular safety profile of the nonsteroidal anti-inflammatory drug (NSAID) celecoxib, a selective inhibitor of COX-2, is...
Conference Coverage
VIDEO: Cardiac inflammation present in RA patients, but resolves with RA therapy
WASHINGTON - Chronic cardiac inflammation is present in rheumatoid arthritis patients and appears to resolve when they achieve a good clinical...